Affluent Medical SAS (AFME) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.319x

Based on the latest financial reports, Affluent Medical SAS (AFME) has a cash flow conversion efficiency ratio of -0.319x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-6.74 Million ≈ $-7.88 Million USD) by net assets (€21.11 Million ≈ $24.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AFME days of operational coverage to measure how many days the company can operate on defensive assets alone.

Affluent Medical SAS - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Affluent Medical SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Affluent Medical SAS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Affluent Medical SAS ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
FCR Immobilien AG
XETRA:FC9
0.076x
Next Technology Holding Inc
NASDAQ:NXTT
-0.003x
Kumho Ind
KO:002990
0.071x
FG Merger II Corp. Unit
NASDAQ:FGMCU
0.002x
Poongwon Precision Co. Ltd.
KQ:371950
-0.270x
An Phat Plastic and Green Environment JSC
VN:AAA
0.021x
Lotus Resources Ltd
AU:LOT
0.006x
Woongjin Co Ltd
KO:016880
0.275x

Annual Cash Flow Conversion Efficiency for Affluent Medical SAS (2016–2024)

The table below shows the annual cash flow conversion efficiency of Affluent Medical SAS from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Affluent Medical SAS market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €30.27 Million
≈ $35.39 Million
€-11.32 Million
≈ $-13.24 Million
-0.374x +2.33%
2023-12-31 €31.47 Million
≈ $36.79 Million
€-12.05 Million
≈ $-14.09 Million
-0.383x -16.94%
2022-12-31 €33.83 Million
≈ $39.55 Million
€-11.08 Million
≈ $-12.95 Million
-0.328x -15.33%
2021-12-31 €43.53 Million
≈ $50.90 Million
€-12.36 Million
≈ $-14.45 Million
-0.284x -12.16%
2020-12-31 €35.29 Million
≈ $41.26 Million
€-8.94 Million
≈ $-10.45 Million
-0.253x +35.66%
2019-12-31 €30.96 Million
≈ $36.20 Million
€-12.19 Million
≈ $-14.25 Million
-0.394x -122.87%
2017-12-31 €61.39 Million
≈ $71.78 Million
€-10.84 Million
≈ $-12.68 Million
-0.177x +4.12%
2016-12-31 €58.87 Million
≈ $68.82 Million
€-10.84 Million
≈ $-12.68 Million
-0.184x --

About Affluent Medical SAS

PA:AFME France Medical Devices
Market Cap
$129.10 Million
€110.43 Million EUR
Market Cap Rank
#18886 Global
#280 in France
Share Price
€2.81
Change (1 day)
+0.36%
52-Week Range
€1.26 - €2.81
All Time High
€8.30
About

Affluent Medical SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardio… Read more